{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:17:43Z","timestamp":1791245863274,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-191","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T10:50:48Z","timestamp":1366023048000},"source":"Crossref","is-referenced-by-count":25,"title":["Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Masao","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"issue":"12","key":"3871_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127 (12): 2893-2917. 10.1002\/ijc.25516.","journal-title":"Int J Cancer"},{"issue":"9","key":"3871_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME: Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009, 27 (9): 1485-1491. 10.1200\/JCO.2008.20.7753.","journal-title":"J Clin Oncol"},{"issue":"9399","key":"3871_CR3","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet. 2003, 362 (9399): 1907-1917. 10.1016\/S0140-6736(03)14964-1.","journal-title":"Lancet"},{"issue":"3","key":"3871_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999, 19 (3): 329-338. 10.1055\/s-2007-1007122.","journal-title":"Semin Liver Dis"},{"issue":"11","key":"3871_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334 (11): 693-699. 10.1056\/NEJM199603143341104.","journal-title":"N Engl J Med"},{"issue":"2","key":"3871_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-2005-871198","volume":"25","author":"JM Llovet","year":"2005","unstructured":"Llovet JM, Schwartz M, Mazzaferro V: Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005, 25 (2): 181-200. 10.1055\/s-2005-871198.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"3871_CR7","first-page":"1121","volume":"18","author":"A Castells","year":"1993","unstructured":"Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodes J: Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993, 18 (5): 1121-1126.","journal-title":"Hepatology"},{"issue":"4","key":"3871_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7326\/0003-4819-138-4-200302180-00008","volume":"138","author":"Y Shiratori","year":"2003","unstructured":"Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, Koike Y, Yoshida H, Omata M: Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med. 2003, 138 (4): 299-306. 10.7326\/0003-4819-138-4-200302180-00008.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3871_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/bjs.6731","volume":"96","author":"S Breitenstein","year":"2009","unstructured":"Breitenstein S, Dimitroulis D, Petrowsky H, Puhan MA, Mullhaupt B, Clavien PA: Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg. 2009, 96 (9): 975-981. 10.1002\/bjs.6731.","journal-title":"Br J Surg"},{"key":"3871_CR10","first-page":"CD001199","volume":"1","author":"M Samuel","year":"2009","unstructured":"Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC: Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev. 2009, 1: CD001199-","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3871_CR11","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1046\/j.1365-2036.2003.01580.x","volume":"17","author":"P Mathurin","year":"2003","unstructured":"Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC: Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther. 2003, 17 (10): 1247-1261. 10.1046\/j.1365-2036.2003.01580.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"24","key":"3871_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199606133342402","volume":"334","author":"Y Muto","year":"1996","unstructured":"Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med. 1996, 334 (24): 1561-1567. 10.1056\/NEJM199606133342402.","journal-title":"N Engl J Med"},{"issue":"13","key":"3871_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJM199904013401315","volume":"340","author":"Y Muto","year":"1999","unstructured":"Muto Y, Moriwaki H, Saito A: Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med. 1999, 340 (13): 1046-1047. 10.1056\/NEJM199904013401315.","journal-title":"N Engl J Med"},{"issue":"2","key":"3871_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1207\/s15327914nc5102_10","volume":"51","author":"T Sano","year":"2005","unstructured":"Sano T, Kagawa M, Okuno M, Ishibashi N, Hashimoto M, Yamamoto M, Suzuki R, Kohno H, Matsushima-Nishiwaki R, Takano Y: Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells. Nutr Cancer. 2005, 51 (2): 197-206. 10.1207\/s15327914nc5102_10.","journal-title":"Nutr Cancer"},{"issue":"6","key":"3871_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/carcin\/bgh093","volume":"25","author":"M Kagawa","year":"2004","unstructured":"Kagawa M, Sano T, Ishibashi N, Hashimoto M, Okuno M, Moriwaki H, Suzuki R, Kohno H, Tanaka T: An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamin-einduced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Carcinogenesis. 2004, 25 (6): 979-985. 10.1093\/carcin\/bgh093.","journal-title":"Carcinogenesis"},{"issue":"6","key":"3871_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1872-034X.2011.00800.x","volume":"41","author":"T Okusaka","year":"2011","unstructured":"Okusaka T, Ueno H, Ikeda M, Morizane C: Phase I and pharmacokinetic clinical trial of oral administration of the acyclic retinoid NIK-333. Hepatol Res. 2011, 41 (6): 542-552. 10.1111\/j.1872-034X.2011.00800.x.","journal-title":"Hepatol Res"},{"issue":"28Suppl","key":"3871_CR17","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1200\/jco.2010.28.15_suppl.4024","volume":"15s","author":"K Okita","year":"2010","unstructured":"Okita K, Matsui O, Kumada H, Tanaka K, Kaneko S, Moriwaki H, Izumi N, Okusaka T, Ohashi Y, Makuuchi M: Effect of peretinoin on recurrence of hepatocellular carcinoma (HCC): Results of a phase II\/III randomized placebo-controlled trial. J Clin Oncol. 2010, 15s (28Suppl): 4024-","journal-title":"J Clin Oncol"},{"issue":"5","key":"3871_CR18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/hep.21383","volume":"44","author":"M Honda","year":"2006","unstructured":"Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S: Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology. 2006, 44 (5): 1122-1138. 10.1002\/hep.21383.","journal-title":"Hepatology"},{"issue":"2","key":"3871_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","volume":"139","author":"M Honda","year":"2010","unstructured":"Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Yamashita T, Nakamura M, Shirasaki T, Horimoto K: Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 2010, 139 (2): 499-509. 10.1053\/j.gastro.2010.04.049.","journal-title":"Gastroenterology"},{"issue":"1","key":"3871_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1006\/bbrc.1995.1199","volume":"207","author":"N Nakamura","year":"1995","unstructured":"Nakamura N, Shidoji Y, Yamada Y, Hatakeyama H, Moriwaki H, Muto Y: Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7. Biochem Biophys Res Commun. 1995, 207 (1): 382-388. 10.1006\/bbrc.1995.1199.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3871_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0168-8278(02)00044-2","volume":"36","author":"I Yasuda","year":"2002","unstructured":"Yasuda I, Shiratori Y, Adachi S, Obora A, Takemura M, Okuno M, Shidoji Y, Seishima M, Muto Y, Moriwaki H: Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines. J Hepatol. 2002, 36 (5): 660-671. 10.1016\/S0168-8278(02)00044-2.","journal-title":"J Hepatol"},{"issue":"3","key":"3871_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/mc.2940100306","volume":"10","author":"Y Yamada","year":"1994","unstructured":"Yamada Y, Shidoji Y, Fukutomi Y, Ishikawa T, Kaneko T, Nakagama H, Imawari M, Moriwaki H, Muto Y: Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog. 1994, 10 (3): 151-158. 10.1002\/mc.2940100306.","journal-title":"Mol Carcinog"},{"issue":"14","key":"3871_CR23","first-page":"3997","volume":"62","author":"M Suzui","year":"2002","unstructured":"Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB: Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res. 2002, 62 (14): 3997-4006.","journal-title":"Cancer Res"},{"issue":"3","key":"3871_CR24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1535-7163.309.3.3","volume":"3","author":"M Suzui","year":"2004","unstructured":"Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB: Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. Mol Cancer Ther. 2004, 3 (3): 309-316.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"3871_CR25","first-page":"1389","volume":"73","author":"Y Muto","year":"1984","unstructured":"Muto Y, Moriwaki H: Antitumor activity of vitamin A and its derivatives. J Natl Cancer Inst. 1984, 73 (6): 1389-1393.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"3871_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bcp.2006.12.030","volume":"73","author":"T Sakabe","year":"2007","unstructured":"Sakabe T, Tsuchiya H, Endo M, Tomita A, Ishii K, Gonda K, Murai R, Takubo K, Hoshikawa Y, Kurimasa A: An antioxidant effect by acyclic retinoid suppresses liver tumor in mice. Biochem Pharmacol. 2007, 73 (9): 1405-1411. 10.1016\/j.bcp.2006.12.030.","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"3871_CR27","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1158\/0008-5472.CAN-12-0028","volume":"72","author":"H Okada","year":"2012","unstructured":"Okada H, Honda M, Campbell JS, Sakai Y, Yamashita T, Takebuchi Y, Hada K, Shirasaki T, Takabatake R, Nakamura M: Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res. 2012, 72 (17): 4459-4471. 10.1158\/0008-5472.CAN-12-0028.","journal-title":"Cancer Res"},{"issue":"4","key":"3871_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/nar\/gkn1028","volume":"37","author":"Y Tomaru","year":"2009","unstructured":"Tomaru Y, Nakanishi M, Miura H, Kimura Y, Ohkawa H, Ohta Y, Hayashizaki Y, Suzuki M: Identification of an inter-transcription factor regulatory network in human hepatoma cells by Matrix RNAi. Nucleic Acids Res. 2009, 37 (4): 1049-1060.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3871_CR29","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/nar\/gkn066","volume":"36","author":"M Nakanishi","year":"2008","unstructured":"Nakanishi M, Tomaru Y, Miura H, Hayashizaki Y, Suzuki M: Identification of transcriptional regulatory cascades in retinoic acid-induced growth arrest of HepG2 cells. Nucleic Acids Res. 2008, 36 (10): 3443-3454. 10.1093\/nar\/gkn066.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3871_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1074\/jbc.M804721200","volume":"284","author":"IP Uray","year":"2009","unstructured":"Uray IP, Shen Q, Seo HS, Kim H, Lamph WW, Bissonnette RP, Brown PH: Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1. J Biol Chem. 2009, 284 (1): 345-353.","journal-title":"J Biol Chem"},{"issue":"31","key":"3871_CR31","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1038\/sj.onc.1206728","volume":"22","author":"Y Ma","year":"2003","unstructured":"Ma Y, Koza-Taylor PH, DiMattia DA, Hames L, Fu H, Dragnev KH, Turi T, Beebe JS, Freemantle SJ, Dmitrovsky E: Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene. 2003, 22 (31): 4924-4932. 10.1038\/sj.onc.1206728.","journal-title":"Oncogene"},{"issue":"10","key":"3871_CR32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4161\/cbt.8.10.8244","volume":"8","author":"X Ye","year":"2009","unstructured":"Ye X, Tao Q, Wang Y, Cheng Y, Lotan R: Mechanisms underlying the induction of the putative human tumor suppressor GPRC5A by retinoic acid. Cancer Biol Ther. 2009, 8 (10): 951-962. 10.4161\/cbt.8.10.8244.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"3871_CR33","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.22506","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008, 48 (4): 1312-1327. 10.1002\/hep.22506.","journal-title":"Hepatology"},{"issue":"6","key":"3871_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jhep.2009.12.034","volume":"52","author":"L Zender","year":"2010","unstructured":"Zender L, Villanueva A, Tovar V, Sia D, Chiang DY, Llovet JM: Cancer gene discovery in hepatocellular carcinoma. J Hepatol. 2010, 52 (6): 921-929. 10.1016\/j.jhep.2009.12.034.","journal-title":"J Hepatol"},{"issue":"6","key":"3871_CR35","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1158\/0008-5472.CAN-06-4433","volume":"67","author":"J Datta","year":"2007","unstructured":"Datta J, Majumder S, Kutay H, Motiwala T, Frankel W, Costa R, Cha HC, MacDougald OA, Jacob ST, Ghoshal K: Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT\/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 2007, 67 (6): 2736-2746. 10.1158\/0008-5472.CAN-06-4433.","journal-title":"Cancer Res"},{"issue":"4","key":"3871_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jcb.21530","volume":"102","author":"AL Fields","year":"2007","unstructured":"Fields AL, Soprano DR, Soprano KJ: Retinoids in biological control and cancer. J Cell Biochem. 2007, 102 (4): 886-898. 10.1002\/jcb.21530.","journal-title":"J Cell Biochem"},{"issue":"19","key":"3871_CR37","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","volume":"359","author":"Y Hoshida","year":"2008","unstructured":"Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008, 359 (19): 1995-2004. 10.1056\/NEJMoa0804525.","journal-title":"N Engl J Med"},{"issue":"2","key":"3871_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00535-009-0164-1","volume":"45","author":"T Utsunomiya","year":"2010","unstructured":"Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori M: Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol. 2010, 45 (2): 146-152. 10.1007\/s00535-009-0164-1.","journal-title":"J Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-191\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T01:08:30Z","timestamp":1688173710000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3871"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-191","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"article-number":"191"}}